Johnson MA, Maggiora GM: Concepts and applications of molecular similarity. 1990, New York, NY, USA: John Wiley and Sons
Google Scholar
Guha R: On the interpretation and interpretability of quantitative structure-activity relationships. J Comput Aided Mol Des. 2008, 22: 857-871. 10.1007/s10822-008-9240-5.
Article
CAS
PubMed
Google Scholar
Gedeck P, Rohde B, Bartels C: QSAR - how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets. J Chem Inf Model. 2006, 46: 1924-1936. 10.1021/ci050413p.
Article
CAS
PubMed
Google Scholar
Brown RD, Martin YC: Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J Chem Inf Comput Sci. 1996, 36: 572-584.
Article
CAS
Google Scholar
Hansch C: A quantitative approach to biological structure-activity relationships. Acct Chem Res. 1969, 2: 232-239. 10.1021/ar50020a002.
Article
CAS
Google Scholar
Wold H: Soft modelling: The basic design and some extension. Systems under indirect observations: Causality, structure, prediction. Edited by: Joerskog KG, Wold H. 1982, Amsterdam: North Holland, 1-54.
Google Scholar
Stanton DT: On the physical interpretation of QSAR models. J Chem Inf Comput Sci. 2003, 43: 1423-1433.
Article
CAS
PubMed
Google Scholar
Guha R, Jurs PC: Development of QSAR models to predict and interpret the biological activity of artemisinin analogues. J Chem Inf Comput Sci. 2004, 44: 1440-1449.
Article
CAS
PubMed
Google Scholar
Melville JL, Hirst JD: TMACC: Interpretable correlation descriptors for quantitative structure-activity relationships. J Chem Inf Model. 2007, 47: 626-634. 10.1021/ci6004178.
Article
CAS
PubMed
Google Scholar
Pastor M, Cruciani G, Mclay I, Pickett S, Clementi S: Grid-independent descriptors (GRIND): A novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem. 2000, 43: 3233-3243. 10.1021/jm000941m.
Article
CAS
PubMed
Google Scholar
Moreau G, Broto P: The autocorrelation of a topological structure: A new molecular descriptor. Nouv J Chim. 1980, 4: 359-360.
CAS
Google Scholar
Golbraikh A, Tropsha A: Beware of q(2)!. J Mol Graphics Modell. 2002, 20: 269-276. 10.1016/S1093-3263(01)00123-1.
Article
CAS
Google Scholar
Hawkins DM, Basak SC, Mills D: Assessing model fit by cross-validation. J Chem Inf Comput Sci. 2003, 43: 579-586.
Article
CAS
PubMed
Google Scholar
Hawkins DM: The problem of overfitting. J Chem Inf Comput Sci. 2004, 44: 1-12.
Article
CAS
PubMed
Google Scholar
Faber NKM: Estimating the uncertainty in estimates of root mean square error of prediction: Application to determining the size of an adequate test set in multivariate calibration. Chemom Intell Lab Syst. 1999, 49: 79-89. 10.1016/S0169-7439(99)00027-1.
Article
CAS
Google Scholar
Johnson SR: The trouble with QSAR (or how I learned to stop worrying and embrace fallacy). J Chem Inf Model. 2008, 48: 25-26. 10.1021/ci700332k.
Article
CAS
PubMed
Google Scholar
Sutherland JJ, O'Brein LA, Weaver DF: Comparison of methods for modelling quantitative structure-activity relationships. J Med Chem. 2004, 47: 5541-5554. 10.1021/jm0497141.
Article
CAS
PubMed
Google Scholar
DePriest SA, Mayer D, Naylor CB, Marshall GR: 3D-QSAR of angiotensin-converting enzyme and thermolysin inhibitors - a comparison of CoMFA models based on deduced and experimentally determined active-site geometries. J Am Chem Soc. 1993, 115: 5372-5384. 10.1021/ja00066a004.
Article
CAS
Google Scholar
Gasteiger J, Marsili M: Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron. 1980, 36: 3219-3228. 10.1016/0040-4020(80)80168-2.
Article
CAS
Google Scholar
Hou TJ, Xia K, Zhang W, Xu XJ: Adme evaluation in drug discovery. 4. Prediction of aqueous solubility based on atom contribution approach. J Chem Inf Comput Sci. 2004, 44: 266-275.
Article
CAS
PubMed
Google Scholar
Wildman SA, Crippen GM: Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci. 1999, 39: 868-873.
Article
CAS
Google Scholar
Natesh R, Schwager SL, Sturrock ED, Acharya KR: Crystal structure of the human ace-lisinopril complex. Nature. 2003, 421: 551-554. 10.1038/nature01370.
Article
CAS
PubMed
Google Scholar
Borer JS: Angiotensin-converting enzyme inhibition: A landmark advance in treatment for cardiovascular disease. Eur Heart J Suppl. 2007, 9: E2-E9. 10.1093/eurheartj/sum037.
Article
CAS
Google Scholar
Patchett AA, Harris E, Tristram EW, Wyvratt MJ, Wu MT, Taub D, Peterson ER, Ikeler TJ, Tenbroeke J, Payne LG, Ondeyka DL, Thorsett ED, Greenlee WJ, Lohr NS, Hoffsommer RD, Joshua H, Ruyle WV, Rothrock JW, Aster SD, Maycock AL, Robinson FM, Hirschmann R, Sweet CS, Ulm EH, Gross DM, Vassil TC, Stone CA: A new class of angiotensin-converting enzyme-inhibitors. Nature. 1980, 288: 280-283. 10.1038/288280a0.
Article
CAS
PubMed
Google Scholar
Ondetti MA, Cushman DW: Angiotensin-converting enzyme-inhibitors - biochemical properties and biological actions. CRC Critical Reviews in Biochemistry. 1984, 16: 381-411. 10.3109/10409238409108720.
Article
CAS
PubMed
Google Scholar
Cushman DW, Cheung HS: Spectrophotometric assay and properties of angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971, 20: 1637-1648. 10.1016/0006-2952(71)90292-9.
Article
CAS
PubMed
Google Scholar
Fuchs S, Xiao HD, Hubert C, Michaud A, Campbell DJ, Adams JW, Capecchi MR, Corvol P, Bernstein KE: Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo. Hypertension. 2008, 51: 267-274. 10.1161/HYPERTENSIONAHA.107.097865.
Article
CAS
PubMed
Google Scholar
Wei L, AlhencGelas F, Corvol P, Clauser E: The 2 homologous domains of human angiotensin-I-converting enzyme are both catalytically active. J Biol Chem. 1991, 266: 9002-9008.
PubMed
CAS
Google Scholar
Corradi HR, Schwager SL, Nchinda AT, Sturrock ED, Acharya KR: Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J Mol Biol. 2006, 357: 964-974. 10.1016/j.jmb.2006.01.048.
Article
CAS
PubMed
Google Scholar
Mayer D, Naylor CB, Motoc I, Marshall GR: A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies. J Comput Aided Mol Des. 1987, 1: 3-16. 10.1007/BF01680553.
Article
CAS
PubMed
Google Scholar
Natesh R, Schwager SLU, Evans HR, Sturrock ED, Acharya KR: Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry. 2004, 43: 8718-8724. 10.1021/bi049480n.
Article
CAS
PubMed
Google Scholar
Tzakos AG, Gerothanassis IP: Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors. Chem Biochem. 2005, 6: 1089-1103.
CAS
Google Scholar
Corradi HR, Chitapi I, Sewell BT, Georgiadis D, Dive V, Sturrock ED, Acharya KR: The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380. Biochemistry. 2007, 46: 5473-5478. 10.1021/bi700275e.
Article
CAS
PubMed
Google Scholar
Fernandez M, Liu X, Wouters MS, Heyberger S, Husain A: Angiotensin I-converting enzyme transition state stabilization by His(1089): Evidence for a catalytic mechansim distinct from other gluzincin metalloproteinases. J Biol Chem. 2001, 276: 4998-5004. 10.1074/jbc.M009009200.
Article
CAS
PubMed
Google Scholar
Dive V, Georgiadis D, Matziari M, Makaritis A, Beau F, Cuniasse P, Yiotakis A: Phosphinic peptides as zinc metalloproteinase inhibitors. Cell Mol Life Sci. 2004, 61: 2010-2019. 10.1007/s00018-004-4050-y.
Article
CAS
PubMed
Google Scholar
van Esch JHM, Tom B, Dive V, Batenburg WW, Georgiadis D, Yiotakis A, van Gool JMG, de Bruijn RJA, de Vries R, Danser AHJ: Selective angiotensin-converting enzyme c-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. Hypertension. 2005, 45: 120-125.
Article
CAS
PubMed
Google Scholar
Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Menard J: Acute angiotensin-converting enzyme inhibition increases the plasma level of the antural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 1996, 97: 839-844. 10.1172/JCI118484.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shen XZ, Xiao HD, Li P, Lin CX, Billet S, Okwan-Duodu D, Adams JW, Bernstein EA, Xu Y, Fuchs S, Bernstein KE: New insights into the role of angiotensin-converting enzyme obtained from the analysis of genetically modified mice. Journal of Molecular Medicine-Jmm. 2008, 86: 679-684. 10.1007/s00109-008-0325-3.
Article
CAS
Google Scholar
Kamen B: Folate and antifolate pharmacology. Semin Oncol. 1997, 24: 30-S18.
Google Scholar
Schweitzer BI, Dicker AP, Bertino JR: Dihydrofolate-reductase as a therapeutic target. FASEB J. 1990, 4: 2441-2452.
Article
CAS
PubMed
Google Scholar
Kompis IM, Islam K, Then RL: DNA and RNA synthesis: Antifolates. Chem Rev. 2005, 105: 593-620. 10.1021/cr0301144.
Article
CAS
PubMed
Google Scholar
Curtin NJ, Hughes AN: Pemetrexed disodium, a novel antifolate with multiple targets. Lancet Oncol. 2001, 2: 298-306. 10.1016/S1470-2045(00)00325-9.
Article
CAS
PubMed
Google Scholar
Allegra CJ, Kovacs JA, Drake JC, Swan JC, Chabner BA, Masur H: Potent invitro and invivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate. J Clin Invest. 1987, 79: 478-482. 10.1172/JCI112837.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lane HC, Laughon BE, Falloon J, Kovacs JA, Davey RT, Polis MA, Masur H: Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med. 1994, 120: 945-955.
Article
CAS
PubMed
Google Scholar
Wang YH, Bruenn JA, Queener SF, Cody V: Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme. Antimicrob Agents Chemother. 2001, 45: 2517-2523. 10.1128/AAC.45.9.2517-2523.2001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klon AE, Heroux A, Ross LJ, Pathak V, Johnson CA, Piper JR, Borhani DW: Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 angstrom and 1.05 angstrom resolution. J Mol Biol. 2002, 320: 677-693. 10.1016/S0022-2836(02)00469-2.
Article
CAS
PubMed
Google Scholar
Cody V, Galitsky N, Luft JR, Pangborn W, Gangjee A, Devraj R, Queener SF, Blakley RL: Comparison of ternary complexes of pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolate. Acta Crystallographica Section D-Biological Crystallography. 1997, 53: 638-649. 10.1107/S090744499700509X.
Article
CAS
Google Scholar
Pignatello R, Guccione S, Forte S, Di Giacomo C, Sorrenti V, Vicari L, Barretta GU, Balzano F, Puglisi G: Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling. Bioorg Med Chem. 2004, 12: 2951-2964. 10.1016/j.bmc.2004.03.040.
Article
CAS
PubMed
Google Scholar
Richter WE, McCormac JJ: Inhibition of mammalian dihydrofolate-reductase by selected 2,4-diaminoquinazolines and related compounds. J Med Chem. 1974, 17: 943-947. 10.1021/jm00255a007.
Article
CAS
PubMed
Google Scholar
Oefner C, Darcy A, Winkler FK: Crystal-structure of human dihydrofolate-reductase complexed with folate. Eur J Biochem. 1988, 174: 377-385. 10.1111/j.1432-1033.1988.tb14108.x.
Article
CAS
PubMed
Google Scholar
Kovalevskaya NV, Smurnyy YD, Polshakov VI, Birdsall B, Bradbury AF, Frenkiel T, Feeney J: Solution structure of human dihydrofolate reductase in its complex with trimethoprim and NADPH. J Biomol NMR. 2005, 33: 69-72. 10.1007/s10858-005-1475-z.
Article
CAS
PubMed
Google Scholar
Bolin JT, Filman DJ, Matthews DA, Hamlin RC, Kraut J: Crystal-structures of escherichia-coli and lactobacillus-casei dihydrofolate-reductase refined at 1.7 Å resolution .1. General features and binding of methotrexate. J Biol Chem. 1982, 257 (22): 13650-13662.
PubMed
CAS
Google Scholar
Gangjee A, Vidwans AP, Vasudevan A, Queener SF, Kisliuk RL, Cody V, Li RM, Galitsky N, Luft JR, Pangborn S: Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents. J Med Chem. 1998, 41: 3426-3434. 10.1021/jm980081y.
Article
CAS
PubMed
Google Scholar
Cody V, Galitsky N, Luft JR, Pangborn W, Queener SF, Gangjee A: Analysis of quinazoline and pyrido[2,3-d]-pyrimidine n9-c10 reversed-bridge antifolates in complex with NADP(+) and pneumocystis carinii dihydrofolate reductase. Acta Crystallographica Section D-Biological Crystallography. 2002, 58: 1393-1399. 10.1107/S0907444902010442.
Article
CAS
Google Scholar
Bennett B, Langan P, Coates L, Mustyakimov M, Schoenborn B, Howell EE, Dealwis C: Neutron diffraction studies of escherichia coli dihydrofolate reductase complexed with methotrexate. Proc Natl Acad Sci USA. 2006, 103: 18493-18498. 10.1073/pnas.0604977103.
Article
CAS
PubMed
Google Scholar
Gangjee A, Adair O, Queener SF: Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido [2,3-d]pyrimidines as dihydrofolate reductase inhibitors. Bioorg Med Chem. 2001, 9: 2929-2935. 10.1016/S0968-0896(01)00223-1.
Article
CAS
PubMed
Google Scholar
Golbraikh A, Tropsha A: QSAR modeling using chirality descriptors derived from molecular topology. J Chem Inf Comput Sci. 2003, 43: 144-154.
Article
CAS
PubMed
Google Scholar
Mittal RR, Harris L, McKinnon RA, Sorich MJ: Partial charge calculation method affects CoMFA QSAR prediction accuracy. J Chem Inf Model. 2009, 49: 704-709. 10.1021/ci800390m.
Article
CAS
PubMed
Google Scholar